Nass Valley Gateway Ltd. (NSVGF)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2022 | 15.78 Million CAD | 15.95% |
| 2021 | 13.61 Million CAD | 44.68% |
| 2020 | 9.41 Million CAD | 64.52% |
| 2019 | 5.72 Million CAD | 30465.56% |
| 2018 | 18.71 Thousand CAD | 2948.05% |
| 2017 | 614.00 CAD | -46.09% |
| 2016 | 1139.00 CAD | -85.54% |
| 2015 | 7875.00 CAD | -94.56% |
| 2014 | 144.64 Thousand CAD | -42.2% |
| 2013 | 250.23 Thousand CAD | 165.46% |
| 2012 | 94.26 Thousand CAD | -73.65% |
| 2011 | 357.81 Thousand CAD | 197.52% |
| 2010 | 120.26 Thousand CAD | -31.93% |
| 2009 | 176.68 Thousand CAD | 97.02% |
| 2008 | 89.67 Thousand CAD | 121.65% |
| 2007 | 40.45 Thousand CAD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 Q1 | 15.84 Million CAD | 0.35% |
| 2023 Q3 | 16.02 Million CAD | 3.04% |
| 2023 Q2 | 15.55 Million CAD | -1.81% |
| 2022 Q2 | 14.57 Million CAD | 6.85% |
| 2022 Q1 | 13.64 Million CAD | 0.19% |
| 2022 FY | 15.78 Million CAD | 15.95% |
| 2022 Q4 | 15.78 Million CAD | -4.36% |
| 2022 Q3 | 16.5 Million CAD | 13.24% |
| 2021 Q2 | 12.88 Million CAD | 9.82% |
| 2021 Q3 | 13.38 Million CAD | 3.88% |
| 2021 Q4 | 13.61 Million CAD | 1.72% |
| 2021 FY | 13.61 Million CAD | 44.68% |
| 2021 Q1 | 11.73 Million CAD | 24.67% |
| 2020 Q2 | 6.12 Million CAD | -3.7% |
| 2020 Q1 | 6.35 Million CAD | 11.17% |
| 2020 FY | 9.41 Million CAD | 64.52% |
| 2020 Q4 | 9.41 Million CAD | 35.17% |
| 2020 Q3 | 6.96 Million CAD | 13.69% |
| 2019 Q1 | 3.85 Million CAD | 20496.43% |
| 2019 FY | 5.72 Million CAD | 30465.56% |
| 2019 Q4 | 5.72 Million CAD | 71.53% |
| 2019 Q3 | 3.33 Million CAD | 2.27% |
| 2019 Q2 | 3.26 Million CAD | -15.4% |
| 2018 Q3 | 281.00 CAD | -84.64% |
| 2018 Q1 | 5330.00 CAD | 768.08% |
| 2018 FY | 18.71 Thousand CAD | 2948.05% |
| 2018 Q4 | 18.71 Thousand CAD | 6560.14% |
| 2018 Q2 | 1829.00 CAD | -65.68% |
| 2017 Q3 | 1177.00 CAD | -90.95% |
| 2017 Q2 | 12.99 Thousand CAD | 261.99% |
| 2017 Q1 | 3591.00 CAD | 215.28% |
| 2017 Q4 | 614.00 CAD | -47.83% |
| 2017 FY | 614.00 CAD | -46.09% |
| 2016 Q3 | 6002.00 CAD | 34.39% |
| 2016 FY | 1139.00 CAD | -85.54% |
| 2016 Q4 | 1139.00 CAD | -81.02% |
| 2016 Q2 | 4466.00 CAD | -23.0% |
| 2016 Q1 | 5800.00 CAD | -26.35% |
| 2015 Q2 | 176.17 Thousand CAD | 9.84% |
| 2015 Q3 | 2696.00 CAD | -98.47% |
| 2015 Q4 | 7875.00 CAD | 192.1% |
| 2015 FY | 7875.00 CAD | -94.56% |
| 2015 Q1 | 160.39 Thousand CAD | 10.89% |
| 2014 Q3 | 342.47 Thousand CAD | 7.13% |
| 2014 Q2 | 319.67 Thousand CAD | 17.96% |
| 2014 Q1 | 271 Thousand CAD | 8.3% |
| 2014 Q4 | 144.64 Thousand CAD | -57.77% |
| 2014 FY | 144.64 Thousand CAD | -42.2% |
| 2013 Q1 | 120.13 Thousand CAD | 27.44% |
| 2013 Q4 | 250.23 Thousand CAD | 20.56% |
| 2013 FY | 250.23 Thousand CAD | 165.46% |
| 2013 Q3 | 207.56 Thousand CAD | 1.07% |
| 2013 Q2 | 205.36 Thousand CAD | 70.95% |
| 2012 FY | 94.26 Thousand CAD | -73.65% |
| 2012 Q1 | 123.73 Thousand CAD | -65.42% |
| 2012 Q4 | 94.26 Thousand CAD | 245.85% |
| 2012 Q2 | 44.42 Thousand CAD | -64.1% |
| 2012 Q3 | 27.25 Thousand CAD | -38.64% |
| 2011 Q2 | 318.82 Thousand CAD | 43.01% |
| 2011 Q1 | 222.93 Thousand CAD | 85.37% |
| 2011 Q4 | 357.81 Thousand CAD | 5.76% |
| 2011 FY | 357.81 Thousand CAD | 197.52% |
| 2011 Q3 | 338.31 Thousand CAD | 6.11% |
| 2010 Q4 | 120.26 Thousand CAD | 45.74% |
| 2010 Q3 | 82.52 Thousand CAD | -28.28% |
| 2010 FY | 120.26 Thousand CAD | -31.93% |
| 2010 Q2 | 115.05 Thousand CAD | -18.87% |
| 2010 Q1 | 141.8 Thousand CAD | -19.74% |
| 2009 Q4 | 176.68 Thousand CAD | -23.1% |
| 2009 FY | 176.68 Thousand CAD | 97.02% |
| 2009 Q3 | 229.77 Thousand CAD | 19.57% |
| 2009 Q2 | 192.16 Thousand CAD | 7.58% |
| 2009 Q1 | 178.61 Thousand CAD | 99.18% |
| 2008 Q3 | 94.75 Thousand CAD | 0.0% |
| 2008 FY | 89.67 Thousand CAD | 121.65% |
| 2008 Q4 | 89.67 Thousand CAD | -5.36% |
| 2007 FY | 40.45 Thousand CAD | 0.0% |
| 2007 Q4 | 40.45 Thousand CAD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| China Medicine Corporation | 21.33 Million USD | 26.006% |
| DH Enchantment Inc. | 989.77 Thousand USD | -1495.008% |
| Exlites Holdings International, Inc. | 33.75 Thousand USD | -46675.032% |
| Itonis, Inc. | 1.14 Million USD | -1276.269% |
| One Step Vending Corp. | 465.73 Thousand USD | -3289.697% |
| MediPal Holdings Corporation | 7.02 Billion USD | 99.775% |
| PD-Rx Pharmaceuticals, Inc. | 1.69 Million USD | -830.179% |
| Pharmagen, Inc. | 8868.81 USD | -177906.305% |
| Suzuken Co., Ltd. | 5.36 Billion USD | 99.706% |